Knowledge Library

Recent Advances in Library Synthesis to Accelerate Medicinal Chemistry Research

Resource Type: Webinar
Resource Topic: Discovery Chemistry Screening Libraries Small Molecules

VIEW

Enabling Drug Discovery with Diverse Lead Generation Platforms

Resource Type: Webinar
Resource Topic: Discovery Chemistry DNA-Encoded Library (DEL) Fragment-Based Drug Discovery High-throughput screening (HTS) Hit Finding Hit-to-Lead in silico services Lead Optimization Mass Spectrometry-based Assays Screening Libraries Screening Services Small Molecules Structural Biology Target Identification and Validation

VIEW

Optimizing Drug Discovery Pipelines with Biophysical Methods

Resource Type: Webinar
Resource Topic: Antibodies Biochemical Assays Biomarkers Biophysical Assays Cell-based Assays DNA-Encoded Library (DEL) Fragment-Based Drug Discovery Hit Finding Hit-to-Lead Mass Spectrometry-based Assays Oncology Phenotypic Assays Screening Libraries Small Molecules Structural Biology Target Identification and Validation Target-Specific Assays Targeted Protein Degradation

VIEW

Discovery of RNA binding molecule using DNA-encoded library technology

Resource Type: Webinar
Resource Topic: Chemical Biology and Proteomics Discovery Chemistry DNA-Encoded Library (DEL) Hit Finding Screening Libraries Small Molecules Target Identification and Validation

VIEW

Empowering Organic Syntheses with Quantum Mechanics Analyses

Syntheses of specifically functionalized molecules continue to be rate limiting steps (RLS) in drug discovery. Improvement in this RLS means investing only in reactions/synthetic sequences that are more likely to succeed. Structural diversifications, different substitution patterns or unique heterocyclic systems can often adversely impact the crucial step(s) of established synthetic sequences or development of feasible …Read More >

Resource Type: Article
Resource Topic: Chemical Biology and Proteomics Discovery Chemistry Hit-to-Lead in silico services Lead Optimization Quantum Mechanics Small Molecules

VIEW

The Synthesis of an Entrepreneur: Merging a Passion for Biochemistry, Synthetic Chemistry, and Bioactive Molecules in Academia

INNOVATION THAT MATTERS By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) Synthetic chemist Joseph Ready believes a huge amount of innovation in the drug industry comes from academia. Academic science is arguably the greatest source of innovation in our ecosystem, yet faces challenges when considering the transition from the lab to early stage …Read More >

Resource Type: Article
Resource Topic: Central Nervous System & Pain Chemical Biology and Proteomics Discovery Chemistry High-throughput screening (HTS) Hit-to-Lead Infectious Diseases Lead Optimization Oncology Small Molecules Target Identification and Validation

VIEW

Drug Hunter: Discovering New Frontiers in Cancer Treatments & Beyond

INNOVATION THAT MATTERS By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) As a self-proclaimed drug hunter, Phil Jones is on a mission to identify the next generation of cancer medicines that improve the lives of patients with cancer. He leads a multi-disciplinary team of scientists at The University of Texas MD Anderson Cancer Center’s Institute …Read More >

Resource Type: Article
Resource Topic: Biomarkers CAR-T Cell Cells and Protein Science Chemical Biology and Proteomics DRUG DISCOVERY AND INNOVATION Hit Finding in vitro biology in vivo Pharmacology Oncology Phenotypic Assays Small Molecules Target Identification and Validation

VIEW

Faster with high-speed fragment screening — Accelerate your drug discovery campaign

In the past, thousands of proteins were considered undruggable. The restricted number of chemical entities available and classical methods limited the exploration of this undevelopable area. Today, the combination of novel chemical modalities and advanced technical approaches has resulted in new clinical candidates from previously undruggable targets. To accelerate your drug discovery campaign, WuXi AppTec´s …Read More >

Resource Type: Article Blog Case Study
Resource Topic: Biochemical Assays Biophysical Assays Fragment-Based Drug Discovery Hit Finding Hit-to-Lead Immunology Lead Optimization Small Molecules Structural Biology

VIEW

Unlocking the potential of DEL | Inspire Hit Discovery

March 4, 2020 – By going commercial, DNA Encoded Library (DEL) technology facilitates rapid discovery and provides access to more chemical entities at lower cost. Over the years, DEL has become a disruptive drug discovery technology in comparison to traditional high-throughput screening (HTS) where it allows expedition of early stage drug discovery. However, DEL platforms don’t succeed …Read More >

Resource Type: Article
Resource Topic: Biophysical Assays DNA-Encoded Library (DEL) Hit Finding Small Molecules Target Identification and Validation

VIEW


Resource Topics
× peptide, amino acid

Contact An Expert Today!